These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Differential expression of Fas ligand in Th1 and Th2 cells is regulated by early growth response gene and NF-AT family members. Dzialo-Hatton R; Milbrandt J; Hockett RD; Weaver CT J Immunol; 2001 Apr; 166(7):4534-42. PubMed ID: 11254710 [TBL] [Abstract][Full Text] [Related]
3. FasL promoter activation by IL-2 through SP1 and NFAT but not Egr-2 and Egr-3. Xiao S; Matsui K; Fine A; Zhu B; Marshak-Rothstein A; Widom RL; Ju ST Eur J Immunol; 1999 Nov; 29(11):3456-65. PubMed ID: 10556800 [TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein induces expression of Fas ligand gene through enhancing transcriptional activity of early growth response factor. Yoo YG; Lee MO J Biol Chem; 2004 Aug; 279(35):36242-9. PubMed ID: 15173177 [TBL] [Abstract][Full Text] [Related]
5. Differential inducibility of the transcriptional repressor ICER and its role in modulation of Fas ligand expression in T and NK lymphocytes. Bodor J; Bodorova J; Bare C; Hodge DL; Young HA; Gress RE Eur J Immunol; 2002 Jan; 32(1):203-12. PubMed ID: 11754361 [TBL] [Abstract][Full Text] [Related]
6. Role of Egr-2 in up-regulation of Fas ligand in normal T cells and aberrant double-negative lpr and gld T cells. Mittelstadt PR; Ashwell JD J Biol Chem; 1999 Jan; 274(5):3222-7. PubMed ID: 9915863 [TBL] [Abstract][Full Text] [Related]
7. Sustained NFAT signaling promotes a Th1-like pattern of gene expression in primary murine CD4+ T cells. Porter CM; Clipstone NA J Immunol; 2002 May; 168(10):4936-45. PubMed ID: 11994444 [TBL] [Abstract][Full Text] [Related]
8. Repression of FasL expression by retinoic acid involves a novel mechanism of inhibition of transactivation function of the nuclear factors of activated T-cells. Lee MO; Kang HJ; Kim YM; Oum JH; Park J Eur J Biochem; 2002 Feb; 269(4):1162-70. PubMed ID: 11856352 [TBL] [Abstract][Full Text] [Related]
9. Inhibitory function of two NFAT family members in lymphoid homeostasis and Th2 development. Ranger AM; Oukka M; Rengarajan J; Glimcher LH Immunity; 1998 Nov; 9(5):627-35. PubMed ID: 9846484 [TBL] [Abstract][Full Text] [Related]
10. Bcl-2-mediated drug resistance: inhibition of apoptosis by blocking nuclear factor of activated T lymphocytes (NFAT)-induced Fas ligand transcription. Srivastava RK; Sasaki CY; Hardwick JM; Longo DL J Exp Med; 1999 Jul; 190(2):253-65. PubMed ID: 10432288 [TBL] [Abstract][Full Text] [Related]
12. Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide inhibit expression of Fas ligand in activated T lymphocytes by regulating c-Myc, NF-kappa B, NF-AT, and early growth factors 2/3. Delgado M; Ganea D J Immunol; 2001 Jan; 166(2):1028-40. PubMed ID: 11145682 [TBL] [Abstract][Full Text] [Related]
13. Sp1 is the major fasl gene activator in abnormal CD4(-)CD8(-)B220(+) T cells of lpr and gld mice. Xiao S; Marshak-Rothstein A; Ju ST Eur J Immunol; 2001 Nov; 31(11):3339-48. PubMed ID: 11745351 [TBL] [Abstract][Full Text] [Related]
14. The IFN regulatory factor family participates in regulation of Fas ligand gene expression in T cells. Chow WA; Fang JJ; Yee JK J Immunol; 2000 Apr; 164(7):3512-8. PubMed ID: 10725705 [TBL] [Abstract][Full Text] [Related]
15. Calcineurin/NFAT-induced up-regulation of the Fas ligand/Fas death pathway is involved in methamphetamine-induced neuronal apoptosis. Jayanthi S; Deng X; Ladenheim B; McCoy MT; Cluster A; Cai NS; Cadet JL Proc Natl Acad Sci U S A; 2005 Jan; 102(3):868-73. PubMed ID: 15644446 [TBL] [Abstract][Full Text] [Related]
16. Fas ligand induction in human NK cells is regulated by redox through a calcineurin-nuclear factors of activated T cell-dependent pathway. Furuke K; Shiraishi M; Mostowski HS; Bloom ET J Immunol; 1999 Feb; 162(4):1988-93. PubMed ID: 9973469 [TBL] [Abstract][Full Text] [Related]
17. HIV Tat binds Egr proteins and enhances Egr-dependent transactivation of the Fas ligand promoter. Yang Y; Dong B; Mittelstadt PR; Xiao H; Ashwell JD J Biol Chem; 2002 May; 277(22):19482-7. PubMed ID: 11909874 [TBL] [Abstract][Full Text] [Related]
18. Novel Egr/NF-AT composite sites mediate activation of the CD95 (APO-1/Fas) ligand promoter in response to T cell stimulation. Li-Weber M; Laur O; Krammer PH Eur J Immunol; 1999 Sep; 29(9):3017-27. PubMed ID: 10508276 [TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of the human FasL promoter-enhancer region. Holtz-Heppelmann CJ; Algeciras A; Badley AD; Paya CV J Biol Chem; 1998 Feb; 273(8):4416-23. PubMed ID: 9468493 [TBL] [Abstract][Full Text] [Related]
20. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation. Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]